Download Download this free, 150-page Pharmaceutical Serialization Playbook jam-packed with strategies for success and pitfalls to avoid.  Learn more >>
Article |

EU adopts counterfeit medicine amendments

Decision could have ‘major’ impact on medicinal product makers; further discussion planned for May 19-20 European GMP Conference in Germany.
Print Reprint
FILED IN:  Applications  > Healthcare  > Pharmaceutical

In mid-February, European Compliance Academy reported that the European Union Parliament adopted the amendments on Directive EC 2001/83/EC to combat counterfeit medicines. The proposed amendments, said the report, “will have to be transferred into national law within two years.”

European Compliance Academy says, “The New Directive on Counterfeit Medicine will have a major impact on everyone involved in manufacturing and quality assurance of medicinal products, APIs, and Excipients. The ECA [European Compliance Academy] plans to cover this important development at future conferences,” including the 4th European GMP Conference, May 19-20 in Heidelberg, Germany. Presenters from Switzerland, Denmark, Germany, the United Kingdom, France, and China will serve as speakers and moderators at the event.

Related Sponsored Content

The 2014 Packaging Trends Report
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!


Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
Each newsletter ranges in frequency from once per month to a few times per month at most.